Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Operating Leases (2020 - 2023)

Agilon Health's Operating Leases history spans 4 years, with the latest figure at $10.5 million for Q1 2023.

  • For Q1 2023, Operating Leases rose 26.67% year-over-year to $10.5 million; the TTM value through Mar 2023 reached $10.5 million, up 26.67%, while the annual FY2022 figure was $9.9 million, 25.06% up from the prior year.
  • Operating Leases reached $10.5 million in Q1 2023 per AGL's latest filing, up from $9.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $11.0 million in Q2 2022 to a low of $5.3 million in Q2 2021.
  • Average Operating Leases over 4 years is $8.2 million, with a median of $8.1 million recorded in 2021.
  • The largest YoY upside for Operating Leases was 106.51% in 2022 against a maximum downside of 25.06% in 2022.
  • A 4-year view of Operating Leases shows it stood at $5.5 million in 2020, then skyrocketed by 43.5% to $7.9 million in 2021, then grew by 25.06% to $9.9 million in 2022, then grew by 5.95% to $10.5 million in 2023.
  • Per Business Quant, the three most recent readings for AGL's Operating Leases are $10.5 million (Q1 2023), $9.9 million (Q4 2022), and $10.3 million (Q3 2022).